CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for TVAX Biomedical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

TVAX Biomedical Inc
10900 S., Suite 700
Phone: (913) 492-2221p:913 492-2221 OLATHE, KS  66061  United States Fax: (913) 492-2243f:913 492-2243

Business Summary
TVAX Biomedical, Inc. is a United States-based biotechnology company. The Company is a clinical stage development company advancing its targeted cell-based immunotherapy for the treatment of cancer. Its immunotherapeutic cancer treatment platform is built scientific and medical research into the interactions between cancer and the immune system. The Company, which focused on treating brain and kidney cancer are supported by positive Phase II clinical data, as well as preclinical and Phase I safety studies. The Company is focused on adapting TVAX Immunotherapy for applications in the veterinary sector with a focus on osteosarcoma in dogs a deadly form of bone cancer.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201112/31/2010YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Member of the Board of Directors, Scientific Advisor Barry S.Skikne 1/1/2017 1/1/2011
CHIEF EXECUTIVE OFFICER WAYNE .CARTER
Immunologist, Scientific Advisor Patrick E.Fields 7/1/2011 7/1/2011
11 additional Officers and Directors records available in full report.

Business Names
Business Name
TVAX Biomedical I, LLC
TVAX Holdings Partners, Inc.

General Information
Number of Employees: 5 (As of 12/31/2011)
Outstanding Shares: 7,848,846 (As of 9/30/2011)
Shareholders: 19
Federal Tax Id: 452762525
Fax Number: (913) 492-2243


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023